SEC Form 4 · accession 0001754045-26-000006
Kodiak Sciences Inc. · KOD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John A. Borgeson
Officer — Chief Financial Officer
Period of report
Jun 4, 2026
Accepted (ET)
Jun 5, 2026 · 5:56 pm EDT
Rule 10b5-1 plan
yes — trade under a plan
Issuer CIK
0001468748
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 4, 2026 | M | 30,000 | $1.04 | A | 241,930 | D | |
| Common StockF2 | Jun 4, 2026 | S | 25,896 | $34.01 | D | 216,034 | D | |
| Common StockF3 | Jun 4, 2026 | S | 4,104 | $34.67 | D | 211,930 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F4 | $1.04 | Jun 4, 2026 | M | 30,000 | D | — | Jun 22, 2026 | Common Stock | 30,000 | 0 | D |
Explanation of responses
- F1The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 29, 2025.
- F2The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $33.49 to $34.48, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in these footnotes.
- F3The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $34.49 to $35.05, inclusive.
- F4The shares subject to this option are fully vested.